| LP307651-2 | Coagulation surface induced.factor substitution^immediately after addition of normal plasma | COMPONENT | 3 |
| LP30766-7 | 45 minutes post dose lactose PO | CHALLENGE | |
| LP307689-2 | Coagulation tissue factor induced.factor substitution^20M post incubation.37 deg c after addition of normal plasma | COMPONENT | 2 |
| LP307700-7 | Coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma | COMPONENT | 2 |
| LP307715-5 | Coagulum lysis^30M post maximum clot amplitude | COMPONENT | 1 |
| LP307716-3 | Fibrinogen Ag/Fibrinogen | COMPONENT | 1 |
| LP307717-1 | Lupus anticoagulant neutralization.dilute phospholipid/Lupus anticoagulant neutralization.high phospholipid | COMPONENT | 1 |
| LP307718-9 | Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of normal plasma | COMPONENT | 1 |
| LP307719-7 | Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of platelet lysate | COMPONENT | 1 |
| LP30772-5 | Columnar cells | COMPONENT | |
| LP307720-5 | Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of saline | COMPONENT | 1 |
| LP307721-3 | Maximum clot firmness^after addition of heparinase | COMPONENT | 1 |
| LP307723-9 | Plasminogen activator tissue type Ag^10M post venistasis | COMPONENT | 1 |
| LP307724-7 | Plasminogen activator tissue type Ag^20M post venistasis | COMPONENT | 1 |
| LP307725-4 | Plasminogen activator tissue type^10M post venistasis | COMPONENT | 2 |
| LP307726-2 | Plasminogen activator tissue type^20M post venistasis | COMPONENT | 2 |
| LP307727-0 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex^10M post venistasis | COMPONENT | 1 |
| LP307728-8 | Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex^20M post venistasis | COMPONENT | 1 |
| LP30773-3 | HIV 1 p17+p18 | COMPONENT | |
| LP30775-8 | Streptocuccus pneumoniae 18 | COMPONENT | |
| LP30776-6 | CD62 cells | COMPONENT | |
| LP307780-9 | Protein C Ag/Coagulation factor VII Ag | COMPONENT | 1 |
| LP307781-7 | Protein C/Coagulation factor IX | COMPONENT | 1 |
| LP307782-5 | Protein S Ag/Coagulation factor VII Ag | COMPONENT | 1 |
| LP307783-3 | Protein S Ag/Coagulation factor X Ag | COMPONENT | 1 |
| LP307784-1 | Prothrombin.activity^immediately after addition of factor II depleted plasma | COMPONENT | 1 |
| LP307785-8 | von Willebrand factor.activity actual/Normal^immediately after 1:1 addition of normal plasma | COMPONENT | 1 |
| LP307786-6 | Face low/Face all | COMPONENT | 1 |
| LP307787-4 | Face lower incisor to chin/Face all | COMPONENT | 1 |
| LP307788-2 | Face lower incisor to chin/Face low | COMPONENT | 1 |
| LP307789-0 | Face lower incisor to chin/Face mid | COMPONENT | 1 |
| LP30779-0 | TCR alpha beta cells | COMPONENT | 1 |
| LP307790-8 | Face mid/Face all | COMPONENT | 1 |
| LP307791-6 | Face mid/Face low | COMPONENT | 1 |
| LP307792-4 | Face upper/Face all | COMPONENT | 1 |
| LP307793-2 | 10-Hydroxycarbazepine^trough | COMPONENT | 1 |
| LP307794-0 | 2-Dechloroethylifosfamide^12H post dose ifosfamide | COMPONENT | 1 |
| LP307795-7 | 2-Dechloroethylifosfamide^1D post dose ifosfamide | COMPONENT | 3 |
| LP307796-5 | 2-Dechloroethylifosfamide^2D post dose ifosfamide | COMPONENT | 3 |
| LP307797-3 | 2-Dechloroethylifosfamide^3D post dose ifosfamide | COMPONENT | 3 |
| LP307798-1 | 2-Dechloroethylifosfamide^3H post dose ifosfamide | COMPONENT | 1 |
| LP307799-9 | 2-Dechloroethylifosfamide^4D post dose ifosfamide | COMPONENT | 3 |
| LP30780-8 | TCR gamma delta cells | COMPONENT | 1 |
| LP307800-5 | 2-Dechloroethylifosfamide^5D post dose ifosfamide | COMPONENT | 3 |
| LP307801-3 | 2-Dechloroethylifosfamide^6D post dose ifosfamide | COMPONENT | 3 |
| LP307802-1 | 2-Dechloroethylifosfamide^6H post dose ifosfamide | COMPONENT | 1 |
| LP307803-9 | 2-Dechloroethylifosfamide^7D post dose ifosfamide | COMPONENT | 3 |
| LP307804-7 | 2-Dechloroethylifosfamide^post dose ifosfamide | COMPONENT | 1 |
| LP307805-4 | 2-Dechloroethylifosfamide^pre dose ifosfamide | COMPONENT | 3 |
| LP307806-2 | 2-Pyridone/N'-Methylnicotinamide | COMPONENT | 1 |